Cantor Fitzgerald Reiterates Overweight on Merck & Co, Maintains $135 Price Target
Portfolio Pulse from Benzinga Newsdesk
Cantor Fitzgerald analyst Louise Chen has reiterated an Overweight rating on Merck & Co (NYSE:MRK) and maintained a price target of $135.

April 01, 2024 | 12:38 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Merck & Co maintains its Overweight rating and $135 price target by Cantor Fitzgerald analyst Louise Chen.
The reiteration of an Overweight rating and a high price target of $135 by a reputable analyst like Louise Chen from Cantor Fitzgerald is likely to instill confidence among investors and could lead to a positive short-term impact on Merck & Co's stock price. The analyst's endorsement serves as a strong signal of the company's robust fundamentals and future growth prospects.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100